CraniUS Appoints World Leading Neurosurgeon to Join Board of Directors
BALTIMORE, Nov. 15, 2022 /PRNewswire/ -- CraniUS LLC, an R&D company focused on building groundbreaking diagnostics and treatments for patients with chronic brain disease, announced today the appointment of Henry Brem, MD to its accomplished Board of Directors.
- Dr. Henry Brem joins CraniUS Board of Directors in further enhancing its mission to facilitate chronic and direct medicine delivery for treating brain disease.
- Over the last several decades, Dr. Brem has built one of the largest and most prestigious brain tumor centers in the world.
- With this, I cannot imagine a more ideal board member to help navigate CraniUS' path forward."
- "I am absolutely thrilled to be joining the CraniUS Board of Directors.